DOLUTEGRAVIR AND LAMIVUDINE Tablets 50/300 mg
Country: Tanzania
Language: English
Source: Tanzania Medicinces & Medical Devices Authority
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Active ingredient:
DOLUTEGRAVIR AND LAMIVUDINE
Available from:
Cipla Limited, INDIA
ATC code:
Antivirals for treatment of HIV infections, combin
INN (International Name):
DOLUTEGRAVIR AND LAMIVUDINE
Dosage:
50/300 mg
Pharmaceutical form:
Tablets
Manufactured by:
Cipla limited, (Goa Unit VII PD II), INDIA
Product summary:
Physical description: Gray coloured,capsule shape biconvex film coated tablets debossed with ''C'' on one side and plain on the other side.; Local technical representative: Phillips Distributors Limited (9823)
Authorization status:
Registered/Compliant
Authorization date:
2021-11-26
